Flow Cytometry, Extracellular: HEK-293F cells transiently transfected with human TNF were stained with TNF Monoclonal Antibody (CSB0050) (green) or isotype control antibody (gray), followed by AlexaFluor 647- conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with TNF Monoclonal Antibody (CSB0050) (blue).

TNF MAb - CSB0050

Catalog #: CSB0050
Extracellular epitope: Yes
Applications: FC   IF   ICC   ELISA   WB  
Reactivity: Human (Others untested)
Size: 100 µg
Detergent Compatibility: Triton X-100 (0.1%)
Fixative Compatibility: Paraformaldehyde (4%)
Concentration: 1 mg/ml
Isotype: IgG2a
Technical Data Sheet
Safety Data Sheet
$475.00
Adding to cart… The item has been added
  • Description
Description
Application Conditions Recommended Concentration
Flow Cytometry, Extracellular Live, Unpermeabilized 1 µg/ml
HEK-293F cells transiently transfected with TNF were stained with TNF Monoclonal Antibody (CSB0050) (green) or isotype control antibody (gray), followed by AlexaFluor 647- conjugated anti- IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with TNF Monoclonal Antibody (CSB0050) (blue).
Application Conditions Recommended Concentration
Immunofluorescence, Extracellular Fixed 4% paraformaldehyde 1 µg/ml
(Left) COS-7 cells transiently transfected TNF were stained with TNF Monoclonal Antibody (CSB0050) followed by AlexaFluor 647 anti- IgG secondary antibody (red) and DAPI (blue). (Top right) COS-7 cells transiently transfected with an empty control vector stained with TNF Monoclonal Antibody. (Bottom right) Isotype control: COS-7 cells transfected with TNF and stained with control MAb.
Application Conditions Recommended Concentration
Immunofluorescence, Intracellular Fixed 4% paraformaldehyde, Permeabilized 0.1% Triton X-100 1 µg/ml
(Left) COS-7 cells transiently transfected TNF were permeabilized and stained with TNF Monoclonal Antibody (CSB0050) followed by AlexaFluor 647 anti- IgG secondary antibody (red) and DAPI (blue). (Top right) COS-7 cells transiently transfected with an empty control vector stained with TNF Monoclonal Antibody. (Bottom right) Isotype control: COS-7 cells transfected with {{target} and stained with control MAb.
Application Conditions Recommended Concentration
Membrane Proteome Specificity
The specificity of TNF Monoclonal Antibody (CSB0050) was tested on the Membrane Proteome Array™ and shown to be specific for TNF. The Membrane Proteome Array™ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array™ represents the industry standard for determining the binding specificity of antibodies and other protein ligands.

CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.

Target TNF
Target Aliases TNF-Alpha, TNFSF2, TNFA, DIF, TNF-A, APC1 protein, Cachectin, TNLG1F
Isotype IgG2a
Species Reactivity Human (Others untested)
Concentration 1 mg/ml

Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.

TNF is a single-pass transmembrane protein with a secreted form. TNF is a cytokine that is part of the tumor necrosis factor superfamily. TNF binds TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. Acting through its receptors, TNF has roles in cellular proliferation and differentiation, lipid metabolism, apoptosis, and coagulation. TNF is involved in cancer, autoimmune diseases, psoriasis, rheumatoid arthritis, ankylosing spondylitis, tuberculosis, insulin resistance, cerebral malaria, septic shock, autosomal dominant polycystic kidney disease, and Alzheimer’s disease.

Circle Icon